Company / Shareholders' Equity
enGene Holdings Inc. Shareholders' Equity History
FY2022-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Shareholders' Equity
$167.7M
FY2025
5-year range
-$76.6M / $272.6M
FY2022-FY2025
Trend
-38.5%
vs FY2024
Sector context
#158 of 214
Health Care
What the data says
At $168M, enGene Holdings Inc.'s shareholders' equity ranks #158 of 214 in the Health Care sector. Improved from $72M to $168M over the past 2 years.
Based on SEC 10-K filings.
$168M in FY2025.
Improved from $72M to $168M over the past 2 years.
Health Care sector context is included.
Shareholders' Equity over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
#158 of 214 in Health CareTop 74% of 214This company $167.7M Sector average $2.6B
▼
-93.5% below sector average
Key checks
Key Insights
- In FY2025, shareholders' equity decreased 38.5% year-over-year.
- Ranks #158 out of 214 companies in the Health Care sector.
Company context
Key Data Points
- Low Piotroski F-Score: 1/9 (multiple financial health concerns)
- Altman Z-Score 0.13 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Shareholders' EquityValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $167.7M | -38.5% |
| FY2024 | $272.6M | +276.1% |
| FY2023 | $72.5M | +194.6% |
| FY2022 | -$76.6M | - |
As of FY2025 · SEC 10-K · Updated Feb 28, 2026